SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-022856
Filing Date
2020-05-07
Accepted
2020-05-07 16:11:59
Documents
60
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mirm-10q_20200331.htm 10-Q 1967248
2 EX-10.1 mirm-ex101_34.htm EX-10.1 154869
3 EX-10.2 mirm-ex102_33.htm EX-10.2 83231
4 EX-10.3 mirm-ex103_32.htm EX-10.3 71340
5 EX-31.1 mirm-ex311_9.htm EX-31.1 18645
6 EX-31.2 mirm-ex312_7.htm EX-31.2 18783
7 EX-32.1 mirm-ex321_10.htm EX-32.1 9719
8 EX-32.2 mirm-ex322_8.htm EX-32.2 9709
  Complete submission text file 0001564590-20-022856.txt   6641654

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT mirm-20200331.xml EX-101.INS 1313491
10 XBRL TAXONOMY EXTENSION SCHEMA mirm-20200331.xsd EX-101.SCH 47340
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mirm-20200331_cal.xml EX-101.CAL 43891
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mirm-20200331_def.xml EX-101.DEF 153522
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE mirm-20200331_lab.xml EX-101.LAB 374720
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mirm-20200331_pre.xml EX-101.PRE 274536
Mailing Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404
Business Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404 650-667-4085
Mirum Pharmaceuticals, Inc. (Filer) CIK: 0001759425 (see all company filings)

IRS No.: 831281555 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38981 | Film No.: 20856482
SIC: 2834 Pharmaceutical Preparations